Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 185

1.

Quantification of run order effect on chromatography - mass spectrometry profiling data.

Surowiec I, Johansson E, Stenlund H, Rantapää-Dahlqvist S, Bergström S, Normark J, Trygg J.

J Chromatogr A. 2018 Jul 5. pii: S0021-9673(18)30861-6. doi: 10.1016/j.chroma.2018.07.019. [Epub ahead of print]

PMID:
30007791
2.

Common genetic variation in the autoimmune regulator (AIRE) locus is associated with autoimmune Addison's disease in Sweden.

Eriksson D, Bianchi M, Landegren N, Dalin F, Skov J, Hultin-Rosenberg L, Mathioudaki A, Nordin J, Hallgren Å, Andersson G, Tandre K, Rantapää Dahlqvist S, Söderkvist P, Rönnblom L, Hulting AL, Wahlberg J, Dahlqvist P, Ekwall O, Meadows JRS, Lindblad-Toh K, Bensing S, Rosengren Pielberg G, Kämpe O.

Sci Rep. 2018 May 30;8(1):8395. doi: 10.1038/s41598-018-26842-2.

3.

The anti-carbamylated protein antibody response is of overall low avidity despite extensive isotype switching.

van Delft MAM, Verheul MK, Burgers LE, Rantapää-Dahlqvist S, van der Helm-van Mil AHM, Huizinga TWJ, Toes REM, Trouw LA.

Rheumatology (Oxford). 2018 May 28. doi: 10.1093/rheumatology/key135. [Epub ahead of print]

PMID:
29846726
4.

The combination of three autoantibodies, ACPA, RF and anti-CarP antibodies is highly specific for rheumatoid arthritis: implications for very early identification of individuals at risk to develop rheumatoid arthritis.

Verheul MK, Böhringer S, van Delft MAM, Jones JD, Rigby WFC, Gan RW, Holers VM, Edison JD, Deane KD, Janssen KMJ, Westra J, Brink M, Rantapää-Dahlqvist S, Huizinga TWJ, van der Helm-van Mil AHM, van der Woude D, Toes REM, Trouw LA.

Arthritis Rheumatol. 2018 May 21. doi: 10.1002/art.40562. [Epub ahead of print]

PMID:
29781231
5.

Concentrations of infliximab and anti-drug antibodies in relation to clinical response in patients with rheumatoid arthritis.

Siljehult F, Ärlestig L, Eriksson C, Rantapää-Dahlqvist S.

Scand J Rheumatol. 2018 Apr 27:1-6. doi: 10.1080/03009742.2018.1433232. [Epub ahead of print]

PMID:
29701536
6.

Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis.

Leonard D, Svenungsson E, Dahlqvist J, Alexsson A, Ärlestig L, Taylor KE, Sandling JK, Bengtsson C, Frodlund M, Jönsen A, Eketjäll S, Jensen-Urstad K, Gunnarsson I, Sjöwall C, Bengtsson AA, Eloranta ML, Syvänen AC, Rantapää-Dahlqvist S, Criswell LA, Rönnblom L.

Ann Rheum Dis. 2018 Jul;77(7):1063-1069. doi: 10.1136/annrheumdis-2017-212614. Epub 2018 Mar 7.

7.

DNA methylation mapping identifies gene regulatory effects in patients with systemic lupus erythematosus.

Imgenberg-Kreuz J, Carlsson Almlöf J, Leonard D, Alexsson A, Nordmark G, Eloranta ML, Rantapää-Dahlqvist S, Bengtsson AA, Jönsen A, Padyukov L, Gunnarsson I, Svenungsson E, Sjöwall C, Rönnblom L, Syvänen AC, Sandling JK.

Ann Rheum Dis. 2018 May;77(5):736-743. doi: 10.1136/annrheumdis-2017-212379. Epub 2018 Feb 1.

8.

Aerobic capacity over 16 years in patients with rheumatoid arthritis: Relationship to disease activity and risk factors for cardiovascular disease.

Hörnberg K, Sundström B, Innala L, Rantapää-Dahlqvist S, Wållberg-Jonsson S.

PLoS One. 2017 Dec 22;12(12):e0190211. doi: 10.1371/journal.pone.0190211. eCollection 2017.

9.

Association Between Marginal Jawbone Loss and Onset of Rheumatoid Arthritis and Relationship to Plasma Levels of RANKL.

Kindstedt E, Johansson L, Palmqvist P, Koskinen Holm C, Kokkonen H, Johansson I, Rantapää Dahlqvist S, Lundberg P.

Arthritis Rheumatol. 2018 Apr;70(4):508-515. doi: 10.1002/art.40394. Epub 2018 Mar 7.

PMID:
29195021
10.

Survivin improves the early recognition of rheumatoid arthritis among patients with arthralgia: A population-based study within two university cities of Sweden.

Erlandsson MC, Turkkila M, Siljehult F, Pullerits R, Eriksson C, Rantapää-Dahlqvist S, Bokarewa MI.

Semin Arthritis Rheum. 2018 Jun;47(6):778-785. doi: 10.1016/j.semarthrit.2017.10.020. Epub 2017 Oct 31.

11.

An increased concentration of receptor activator of nuclear factor kappa-B ligand pre-dates the onset of rheumatoid arthritis.

Johansson L, Ärlestig L, Kokkonen H, Brink M, Rantapää-Dahlqvist S.

Rheumatology (Oxford). 2017 Dec 1;56(12):2190-2196. doi: 10.1093/rheumatology/kex339.

PMID:
29029341
12.

Validation of the EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis.

Burgers LE, Siljehult F, Ten Brinck RM, van Steenbergen HW, Landewé RBM, Rantapää-Dahlqvist S, van der Helm-van Mil AHM.

Rheumatology (Oxford). 2017 Dec 1;56(12):2123-2128. doi: 10.1093/rheumatology/kex324.

PMID:
28968699
13.

Cardiovascular risk factors predate the onset of symptoms of rheumatoid arthritis: a nested case-control study.

Kokkonen H, Stenlund H, Rantapää-Dahlqvist S.

Arthritis Res Ther. 2017 Jun 30;19(1):148. doi: 10.1186/s13075-017-1351-8.

14.

The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identical.

Boeters DM, Mangnus L, Ajeganova S, Lindqvist E, Svensson B, Toes REM, Trouw LA, Huizinga TWJ, Berenbaum F, Morel J, Rantapää-Dahlqvist S, van der Helm-van Mil AHM.

Arthritis Res Ther. 2017 May 31;19(1):115. doi: 10.1186/s13075-017-1324-y.

15.

Receptor activator of nuclear factor kappa-B ligand (RANKL) but not sclerostin or gene polymorphisms is related to joint destruction in early rheumatoid arthritis.

Boman A, Kokkonen H, Ärlestig L, Berglin E, Rantapää-Dahlqvist S.

Clin Rheumatol. 2017 May;36(5):1005-1012. doi: 10.1007/s10067-017-3570-4. Epub 2017 Feb 11.

16.

EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis.

van Steenbergen HW, Aletaha D, Beaart-van de Voorde LJ, Brouwer E, Codreanu C, Combe B, Fonseca JE, Hetland ML, Humby F, Kvien TK, Niedermann K, Nuño L, Oliver S, Rantapää-Dahlqvist S, Raza K, van Schaardenburg D, Schett G, De Smet L, Szücs G, Vencovský J, Wiland P, de Wit M, Landewé RL, van der Helm-van Mil AH.

Ann Rheum Dis. 2017 Mar;76(3):491-496. doi: 10.1136/annrheumdis-2016-209846. Epub 2016 Oct 6.

PMID:
27991858
17.

Disease Activity and Increased Risk of Cardiovascular Death among Patients with Psoriatic Arthritis.

Juneblad K, Rantapää-Dahlqvist S, Alenius GM.

J Rheumatol. 2016 Dec;43(12):2155-2161. Epub 2016 Oct 1.

PMID:
27909142
18.

Abdominal obesity, gender and the risk of rheumatoid arthritis - a nested case-control study.

Ljung L, Rantapää-Dahlqvist S.

Arthritis Res Ther. 2016 Nov 29;18(1):277.

19.

Erratum to: Concentration of antibodies against Porphyromonas gingivalisis increased before the onset of symptoms of rheumatoid arthritis.

Johansson L, Sherina N, Kharlamova N, Potempa B, Larsson B, Israelsson L, Potempa J, Rantapää-Dahlqvist S, Lundberg K.

Arthritis Res Ther. 2016 Nov 4;18(1):257. No abstract available.

20.

Metabolite and Lipid Profiling of Biobank Plasma Samples Collected Prior to Onset of Rheumatoid Arthritis.

Surowiec I, Ärlestig L, Rantapää-Dahlqvist S, Trygg J.

PLoS One. 2016 Oct 18;11(10):e0164196. doi: 10.1371/journal.pone.0164196. eCollection 2016.

21.

Concentration of antibodies against Porphyromonas gingivalis is increased before the onset of symptoms of rheumatoid arthritis.

Johansson L, Sherina N, Kharlamova N, Potempa B, Larsson B, Israelsson L, Potempa J, Rantapää-Dahlqvist S, Lundberg K.

Arthritis Res Ther. 2016 Sep 7;18:201. doi: 10.1186/s13075-016-1100-4. Erratum in: Arthritis Res Ther. 2016 Nov 4;18(1):257.

22.

Antibodies directed against endogenous and exogenous citrullinated antigens pre-date the onset of rheumatoid arthritis.

Johansson L, Pratesi F, Brink M, Ärlestig L, D'Amato C, Bartaloni D, Migliorini P, Rantapää-Dahlqvist S.

Arthritis Res Ther. 2016 Jun 3;18(1):127. doi: 10.1186/s13075-016-1031-0.

23.

Response to biological treatment and subsequent risk of coronary events in rheumatoid arthritis.

Ljung L, Rantapää-Dahlqvist S, Jacobsson LT, Askling J.

Ann Rheum Dis. 2016 Dec;75(12):2087-2094. doi: 10.1136/annrheumdis-2015-208995. Epub 2016 Mar 16.

PMID:
26984007
24.

High sodium chloride consumption enhances the effects of smoking but does not interact with SGK1 polymorphisms in the development of ACPA-positive status in patients with RA.

Jiang X, Sundström B, Alfredsson L, Klareskog L, Rantapää-Dahlqvist S, Bengtsson C.

Ann Rheum Dis. 2016 May;75(5):943-6. doi: 10.1136/annrheumdis-2015-209009. Epub 2016 Feb 22. No abstract available.

PMID:
26903441
25.

Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis.

Brink M, Hansson M, Mathsson-Alm L, Wijayatunga P, Verheul MK, Trouw LA, Holmdahl R, Rönnelid J, Klareskog L, Rantapää-Dahlqvist S.

Arthritis Res Ther. 2016 Feb 9;18:43. doi: 10.1186/s13075-016-0940-2.

26.

Co-morbidity in patients with early rheumatoid arthritis - inflammation matters.

Innala L, Sjöberg C, Möller B, Ljung L, Smedby T, Södergren A, Magnusson S, Rantapää-Dahlqvist S, Wållberg-Jonsson S.

Arthritis Res Ther. 2016 Jan 28;18:33. doi: 10.1186/s13075-016-0928-y.

27.

Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts.

Jönsen A, Hjalte F, Willim M, Carlsson KS, Sjöwall C, Svenungsson E, Leonard D, Bengtsson C, Rantapää-Dahlqvist S, Pettersson S, Gunnarsson I, Zickert A, Gustafsson JT, Rönnblom L, Petersson IF, Bengtsson AA, Nived O.

Semin Arthritis Rheum. 2016 Jun;45(6):684-90. doi: 10.1016/j.semarthrit.2015.11.013. Epub 2015 Dec 2.

PMID:
26743074
28.

Is Lipoprotein-Associated Phospholipase A2 a Link between Inflammation and Subclinical Atherosclerosis in Rheumatoid Arthritis?

Södergren A, Karp K, Bengtsson C, Möller B, Rantapää-Dahlqvist S, Wållberg-Jonsson S.

Biomed Res Int. 2015;2015:673018. doi: 10.1155/2015/673018. Epub 2015 Oct 4.

29.

Studies on ageing and the severity of radiographic joint damage in rheumatoid arthritis.

Mangnus L, van Steenbergen HW, Lindqvist E, Brouwer E, Reijnierse M, Huizinga TW, Gregersen PK, Berglin E, Rantapää-Dahlqvist S, van der Heijde D, van der Helm-van Mil AH.

Arthritis Res Ther. 2015 Aug 24;17:222. doi: 10.1186/s13075-015-0740-0.

30.

An Immunochip-based interaction study of contrasting interaction effects with smoking in ACPA-positive versus ACPA-negative rheumatoid arthritis.

Jiang X, Källberg H, Chen Z, Ärlestig L, Rantapää-Dahlqvist S, Davila S, Klareskog L, Padyukov L, Alfredsson L.

Rheumatology (Oxford). 2016 Jan;55(1):149-55. doi: 10.1093/rheumatology/kev285. Epub 2015 Aug 13.

PMID:
26272072
31.

Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases.

Lenz TL, Deutsch AJ, Han B, Hu X, Okada Y, Eyre S, Knapp M, Zhernakova A, Huizinga TW, Abecasis G, Becker J, Boeckxstaens GE, Chen WM, Franke A, Gladman DD, Gockel I, Gutierrez-Achury J, Martin J, Nair RP, Nöthen MM, Onengut-Gumuscu S, Rahman P, Rantapää-Dahlqvist S, Stuart PE, Tsoi LC, van Heel DA, Worthington J, Wouters MM, Klareskog L, Elder JT, Gregersen PK, Schumacher J, Rich SS, Wijmenga C, Sunyaev SR, de Bakker PI, Raychaudhuri S.

Nat Genet. 2015 Sep;47(9):1085-90. doi: 10.1038/ng.3379. Epub 2015 Aug 10.

32.

Genetic Variants of the NLRP3 Inflammasome Are Associated with Stroke in Patients with Rheumatoid Arthritis.

Kastbom A, Ärlestig L, Rantapää-Dahlqvist S.

J Rheumatol. 2015 Oct;42(10):1740-5. doi: 10.3899/jrheum.141529. Epub 2015 Jul 15.

PMID:
26178285
33.

Associations of antibodies against citrullinated peptides with human leukocyte antigen-shared epitope and smoking prior to the development of rheumatoid arthritis.

Kokkonen H, Brink M, Hansson M, Lassen E, Mathsson-Alm L, Holmdahl R, Rönnelid J, Klareskog L, Rantapää-Dahlqvist S.

Arthritis Res Ther. 2015 May 20;17:125. doi: 10.1186/s13075-015-0638-x.

34.

Association analysis of copy numbers of FC-gamma receptor genes for rheumatoid arthritis and other immune-mediated phenotypes.

Franke L, el Bannoudi H, Jansen DT, Kok K, Trynka G, Diogo D, Swertz M, Fransen K, Knevel R, Gutierrez-Achury J, Ärlestig L, Greenberg JD, Kremer J, Pappas DA, Kanterakis A, Weersma RK, van der Helm-van Mil AH, Guryev V, Rantapää-Dahlqvist S, Gregersen PK, Plenge RM, Wijmenga C, Huizinga TW, Ioan-Facsinay A, Toes RE, Zhernakova A.

Eur J Hum Genet. 2016 Feb;24(2):263-70. doi: 10.1038/ejhg.2015.95. Epub 2015 May 13.

35.

Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage.

Brink M, Verheul MK, Rönnelid J, Berglin E, Holmdahl R, Toes RE, Klareskog L, Trouw LA, Rantapää-Dahlqvist S.

Arthritis Res Ther. 2015 Feb 7;17:25. doi: 10.1186/s13075-015-0536-2.

36.

The Extent of Subclinical Atherosclerosis Is Partially Predicted by the Inflammatory Load: A Prospective Study over 5 Years in Patients with Rheumatoid Arthritis and Matched Controls.

Södergren A, Karp K, Bengtsson C, Möller B, Rantapää-Dahlqvist S, Wållberg-Jonsson S.

J Rheumatol. 2015 Jun;42(6):935-42. doi: 10.3899/jrheum.140694. Epub 2015 Apr 15.

PMID:
25877503
37.

Association of valine and leucine at HLA-DRB1 position 11 with radiographic progression in rheumatoid arthritis, independent of the shared epitope alleles but not independent of anti-citrullinated protein antibodies.

van Steenbergen HW, Raychaudhuri S, Rodríguez-Rodríguez L, Rantapää-Dahlqvist S, Berglin E, Toes RE, Huizinga TW, Fernández-Gutiérrez B, Gregersen PK, van der Helm-van Mil AH.

Arthritis Rheumatol. 2015 Apr;67(4):877-86. doi: 10.1002/art.39018.

38.

A genetic study on C5-TRAF1 and progression of joint damage in rheumatoid arthritis.

van Steenbergen HW, Rodríguez-Rodríguez L, Berglin E, Zhernakova A, Knevel R, Ivorra-Cortés J, Huizinga TW, Fernández-Gutiérrez B, Gregersen PK, Rantapää-Dahlqvist S, van der Helm-van Mil AH.

Arthritis Res Ther. 2015 Jan 8;17:1. doi: 10.1186/s13075-014-0514-0.

39.

Diet and alcohol as risk factors for rheumatoid arthritis: a nested case-control study.

Sundström B, Johansson I, Rantapää-Dahlqvist S.

Rheumatol Int. 2015 Mar;35(3):533-9. doi: 10.1007/s00296-014-3185-x. Epub 2014 Nov 27.

PMID:
25428595
40.

Interaction between dietary sodium and smoking increases the risk for rheumatoid arthritis: results from a nested case-control study.

Sundström B, Johansson I, Rantapää-Dahlqvist S.

Rheumatology (Oxford). 2015 Mar;54(3):487-93. doi: 10.1093/rheumatology/keu330. Epub 2014 Sep 10.

PMID:
25209067
41.

The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study.

Ljung L, Askling J, Rantapää-Dahlqvist S, Jacobsson L; ARTIS Study Group.

Arthritis Res Ther. 2014 Jun 18;16(3):R127. doi: 10.1186/ar4584.

42.

Age at onset determines severity and choice of treatment in early rheumatoid arthritis: a prospective study.

Innala L, Berglin E, Möller B, Ljung L, Smedby T, Södergren A, Magnusson S, Rantapää-Dahlqvist S, Wållberg-Jonsson S.

Arthritis Res Ther. 2014 Apr 14;16(2):R94. doi: 10.1186/ar4540.

43.

The autoantibody repertoire in periodontitis: a role in the induction of autoimmunity to citrullinated proteins in rheumatoid arthritis? Antibodies against uncitrullinated peptides seem to occur prior to the antibodies to the corresponding citrullinated peptides.

Brink M, Hansson M, Rönnelid J, Klareskog L, Rantapää Dahlqvist S.

Ann Rheum Dis. 2014 Jul;73(7):e46. doi: 10.1136/annrheumdis-2014-205498. Epub 2014 Mar 25. No abstract available.

PMID:
24667899
44.

Fine mapping seronegative and seropositive rheumatoid arthritis to shared and distinct HLA alleles by adjusting for the effects of heterogeneity.

Han B, Diogo D, Eyre S, Kallberg H, Zhernakova A, Bowes J, Padyukov L, Okada Y, González-Gay MA, Rantapää-Dahlqvist S, Martin J, Huizinga TW, Plenge RM, Worthington J, Gregersen PK, Klareskog L, de Bakker PI, Raychaudhuri S.

Am J Hum Genet. 2014 Apr 3;94(4):522-32. doi: 10.1016/j.ajhg.2014.02.013. Epub 2014 Mar 20.

45.

Does a genetic variant in FOXO3A predict a milder course of rheumatoid arthritis?

van Steenbergen HW, Rantapää-Dahlqvist S, van Nies JA, Berglin E, Huizinga TW, Gregersen PK, van der Helm-van Mil AH.

Arthritis Rheumatol. 2014 Jun;66(6):1678-81. doi: 10.1002/art.38405. No abstract available.

46.

High-density genotyping of immune loci in Koreans and Europeans identifies eight new rheumatoid arthritis risk loci.

Kim K, Bang SY, Lee HS, Cho SK, Choi CB, Sung YK, Kim TH, Jun JB, Yoo DH, Kang YM, Kim SK, Suh CH, Shim SC, Lee SS, Lee J, Chung WT, Choe JY, Shin HD, Lee JY, Han BG, Nath SK, Eyre S, Bowes J, Pappas DA, Kremer JM, Gonzalez-Gay MA, Rodriguez-Rodriguez L, Ärlestig L, Okada Y, Diogo D, Liao KP, Karlson EW, Raychaudhuri S, Rantapää-Dahlqvist S, Martin J, Klareskog L, Padyukov L, Gregersen PK, Worthington J, Greenberg JD, Plenge RM, Bae SC.

Ann Rheum Dis. 2015 Mar;74(3):e13. doi: 10.1136/annrheumdis-2013-204749. Epub 2014 Feb 14.

47.

Cytokines in relation to autoantibodies before onset of symptoms for systemic lupus erythematosus.

Eriksson C, Rantapää-Dahlqvist S.

Lupus. 2014 Jun;23(7):691-6. doi: 10.1177/0961203314523869. Epub 2014 Feb 14.

PMID:
24531079
48.

Survivin but not Fms-like tyrosine kinase 3 ligand is up-regulated before the onset of rheumatoid arthritis: a pilot study.

Bokarewa M, Brink M, Erlandsson M, Rantapää Dahlqvist S.

Arthritis Res Ther. 2014 Feb 5;16(1):R45. doi: 10.1186/ar4474.

49.

Genetics of rheumatoid arthritis contributes to biology and drug discovery.

Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K, Kochi Y, Ohmura K, Suzuki A, Yoshida S, Graham RR, Manoharan A, Ortmann W, Bhangale T, Denny JC, Carroll RJ, Eyler AE, Greenberg JD, Kremer JM, Pappas DA, Jiang L, Yin J, Ye L, Su DF, Yang J, Xie G, Keystone E, Westra HJ, Esko T, Metspalu A, Zhou X, Gupta N, Mirel D, Stahl EA, Diogo D, Cui J, Liao K, Guo MH, Myouzen K, Kawaguchi T, Coenen MJ, van Riel PL, van de Laar MA, Guchelaar HJ, Huizinga TW, Dieudé P, Mariette X, Bridges SL Jr, Zhernakova A, Toes RE, Tak PP, Miceli-Richard C, Bang SY, Lee HS, Martin J, Gonzalez-Gay MA, Rodriguez-Rodriguez L, Rantapää-Dahlqvist S, Arlestig L, Choi HK, Kamatani Y, Galan P, Lathrop M; RACI consortium; GARNET consortium, Eyre S, Bowes J, Barton A, de Vries N, Moreland LW, Criswell LA, Karlson EW, Taniguchi A, Yamada R, Kubo M, Liu JS, Bae SC, Worthington J, Padyukov L, Klareskog L, Gregersen PK, Raychaudhuri S, Stranger BE, De Jager PL, Franke L, Visscher PM, Brown MA, Yamanaka H, Mimori T, Takahashi A, Xu H, Behrens TW, Siminovitch KA, Momohara S, Matsuda F, Yamamoto K, Plenge RM.

Nature. 2014 Feb 20;506(7488):376-81. doi: 10.1038/nature12873. Epub 2013 Dec 25.

50.

Coronary heart disease in systemic lupus erythematosus is associated with interferon regulatory factor-8 gene variants.

Leonard D, Svenungsson E, Sandling JK, Berggren O, Jönsen A, Bengtsson C, Wang C, Jensen-Urstad K, Granstam SO, Bengtsson AA, Gustafsson JT, Gunnarsson I, Rantapää-Dahlqvist S, Nordmark G, Eloranta ML, Syvänen AC, Rönnblom L.

Circ Cardiovasc Genet. 2013 Jun;6(3):255-63. doi: 10.1161/CIRCGENETICS.113.000044. Epub 2013 May 9.

Supplemental Content

Loading ...
Support Center